Dong-A Pharm to file a new drug application for DA-9601

Published: 2002-03-20 06:58:00

Updated: 2002-03-20 06:58:00

Dong-A Pharm, a drug manufacturer of Gaster (famotidine), has filed a new drug application for its gastric mucosa protective DA-9601 to the Korea Food and Drug Administration on March 15th, after completing its Phase III trials in the middle of last December.

Hanyang Securities says that the K...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK